hyundai bioscience 048410 Algorithm Investment Report

1. Performance Analysis of Algorithm (consolidated) 048410 Date
Period 3 months 100-m won
2020.12 2021.12 2022.12 Average 2022.09 2022.12 2023.03 2023.06 2023.09 2023.12
IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con) IFRS(Con)
Sales 125 92 79 99 24 17 32 32 38 44 26
O-profit -45 -98 -264 -136 -73 -109 -23 -20 -22 -25 -56
N-income -83 -201 -158 -147 34 -111 -21 -23 -50 -108 -30
O-rate -36.0 -106.5 -334.2 -158.9 -304.2 -641.2 -71.9 -62.5 -59.6 -56.8 -269.9
N-rate -66.4 -218.5 -200.0 -161.6 141.7 -652.9 -65.6 -71.9 -132.1 -242.8 -162.2
ROE -15.9 -32.6 -27.1 -25.2 19.7 -28.3 -7.8 -8.2 -12.8 -21.9 -6.1
Debt-ratio 79.2 30.8 15.6 41.9 14.8 15.6 15.1 12.5 12.3 12.2 14.5
Quick-ratio 391.7 182.1 232.2 268.7 339.8 232.2 228.2 265.7 254.4 246.1 266.5
reserve-ratio 244.4 272.5 247.0 254.7 302.5 247.0 240.2 229.6 169.5 121.7 254.8
EPS -208 -505 -397 -370 85 -279 -53 -58 -125 -270 -76
BPS 1,314 1,547 1,462 1,441 1,731 1,462 1,432 1,387 1,263 1,150 1,503
Dividends 0 0 0 0
2023-10-31
Major
Financial
Information
Recent Annual Performance Recent quarterly performance Estimate
Average
Gap
(Indication /
stock)
Color
High price ~ -35 %
High mid ~ -45 %
Mid ~ -55 %
Low mid ~ -66 %
Low price ~ -76 %
Indication price Range Current stock price Company score
21,492 W 21,492 W 17,477 W
17,477 W 17,477 W 13,462 W Evaluation
25,507 W 25,507 W~ 21,492 W
39,050 W
39.4
13,462 W 13,462 W 9,447 W
High price
Sell
9,447 W 9,447 W 0 W
Industrial name of the company
The number of
All industries
Algorithm
Industry ranking
Total number of
listed companies
Algorithm
company ranking
Investment
opinion
Cosmetics 79 61 3,763 2,686
9,447원
13,462원
17,477원
21,492원
25,507원
High price 39,050원
-76%
-66%
-55%
-45%
-35%
-80%
-70%
-60%
-50%
-40%
-30%
-20%
-10%
0.%
0W
5,000W
10,000W
15,000W
20,000W
25,000W
30,000W
35,000W
40,000W
45,000W
Low price Low mid Mid High mid High price
Indication price chart (Consolidated)
Indication price
hyundai bioscience corp
Gap
hyundai bioscience corp

2. [Price for scheduled purchasing]
Arbitrarily made
Algorithm stocks Trading Strategies (consolidated) 048410 Date
Period
Gap
(Indication /
stock)
Color
2023-10-31
3 months
Current stock price Evaluation
Stock price rise
probability score
Investment opinion Prospective purchase amount
39,050 W High price 40.4 Sell 2,500,000 W
Suggested Purchase
Amount 293,124 W
Number of stocks
purchased 8
Indication price Range Buying / Selling Buying / Selling [Stocks]
High price 25,507 W 25,507 W~ ~ 21,492 W -35 % 101,655 W 4
High mid 21,492 W 21,492 W ~ 17,477 W -45 % 131,795 W 6
Mid 17,477 W 17,477 W ~ 13,462 W -55 % 161,934 W 9
Low mid 13,462 W 13,462 W ~ 9,447 W -66 % 192,074 W 14
low price 9,447 W 9,447 W ~ 0 W -76 % 222,214 W 24
Stock price rise
probability score
A Sector 52.2 47.5 40.2 54.2 47.5 44.6
40.4
B Sector 18.8 22.1 31.7 54.2 22.1 50.0
Total average
2023.06.01 2023.06.30 2023.07.28 2023.08.28 2023.09.25 2023.10.30
35.5 34.8 35.9 19.2 34.8 47.3
45 % 27 %
2023.06.30 2023.07.28 2023.08.28 2023.09.25 2023.10.30
Total of
increase rate
Total score
A Sector -10 % -18 % 26 % -14 % -6 %
-3 % 53.3
B Sector 15 % 30 % 42 % -145 % 56 %
Total average -2 % 3 % -87 %
52
48
40
54
47
45
19
22
32
54
22
50
35 35 36
19
35
47
0
10
20
30
40
50
60
2023.06.01 2023.06.30 2023.07.28 2023.08.28 2023.09.25 2023.10.30
Stock price rise probability score
A sector
B sector
Total average
-10% -18%
26%
-14% -6%
15%
30% 42%
-145%
56%
-2% 3%
-87%
45%
27%
-200%
-150%
-100%
-50%
0%
50%
100%
2023.06.30 2023.07.28 2023.08.28 2023.09.25 2023.10.30
Increase rate of stock price rise
A sector
B sector
Total average
hyundai bioscience corp

3. 정보와
완전
정보
결
투자판단
있습니
위배
무단으
숙지하
Compliance notice
① The information provided by The Algorithm Company Analysis
Consulting is obtained through reliable data and information and
The Algorithm Company Analysis Program (TACAP), but its
accuracy or completeness are not guaranteed. Furthermore, it may
change over time.Therefore, we are not legally responsible for the
results of the data provided by The Algorithm Company Analysis
Consulting because of information errors or omissions.
② The Algorithm Company Analysis Consulting and all the
information provided on it site are reference materials for
investment decisions and the final responsibility of investment is
up to users utilizing this information.
③ The Algorithm Company Analysis Consulting and its site do not
do anything that violates the related laws such as discretionary
transaction.
④ Users can not reallocate and recycle the information provided by
The Algorithm Company Analysis Consulting firm let alone the
information provided by its Site.
⑤ Be sure to know about application period of this algorithm
analysis report in order to improve its accuracy.
Tel : 070 - 4667 - 5009 Email : tacac@tacac.co.kr
Homepage : tacac.co.kr Blog : tacac.blog.me
SERVICES
M&A, IPO, RECOVER, CORPORATE RESTRUCTURING, MANAGEMENT OF
TECHNOLOGY, BUSINESS STRATEGY, FAMILY BUSINESS
Request : http://tacac.co.kr/?page_id=1374
①
Consulting is o
The Algorithm
accuracy or com
change over tim
results of the d
Consulting bec
②
information pr
investment dec
up
③
do anything th
transaction.
④
The Algorithm
information pr
⑤
analysis report